application) The goal of the Animal Core is to provide animal-related resources to support this PPG in the following aims: 1) to provide a central facility for the purchase and care of Sprague Dawley rats needed for Projects 1-4 and Core B (Cell Culture Core), 2) to provide Projects 2 and 4 with animals rendered cholinergically dysfunctional by fimbrial lesions, 3) to provide projects 1,3, and 4 with aged and genotyped mice that overexpress both amyloid precursor protein (APP) and presenilin 1 (PS1), 4) to provide Projects 3 and 4 with standardized histochemical immunocytochemical analyses of gene transfer efficiency and function in brain tissues, and 5) to provide Projects 1-4 with a core facility for stereological analyses of marker-density in brain regions labelled in Aims 3 and 4 above or in their own studies.
These aims are modified from the previous funding period in several significant manners. The application has been augmented by the addition of an important model for the overexpression of gene products associated with Alzheimer's disease: APP and PS1. This model will serve to test the actions of novel drugs and gene-therapies on brain function, and to determine how over-expression of these Alzheimer's type products affects the ectopic expression of somatic transgenes administered virally or nonvirally. Another modification involves a greater emphasis on neuroprotection models, with reduced emphasis on behavioral studies. This focus on studying the protective actions of variety of potential therapeutic actions is accompanied by a new stereological set-up that will permit regular unbiased quantification of markers in brain tissue.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG010485-12
Application #
6642873
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2002-08-15
Project End
2003-07-31
Budget Start
Budget End
Support Year
12
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Florida
Department
Type
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Richter, Frank; Koulen, Peter; Kaja, Simon (2016) N-Palmitoylethanolamine Prevents the Run-down of Amplitudes in Cortical Spreading Depression Possibly Implicating Proinflammatory Cytokine Release. Sci Rep 6:23481
Means, John C; Gerdes, Bryan C; Kaja, Simon et al. (2016) Caspase-3-Dependent Proteolytic Cleavage of Tau Causes Neurofibrillary Tangles and Results in Cognitive Impairment During Normal Aging. Neurochem Res 41:2278-88
Montgomery, Christa L; Keereetaweep, Jantana; Johnson, Heather M et al. (2016) Changes in Retinal N-Acylethanolamines and their Oxylipin Derivatives During the Development of Visual Impairment in a Mouse Model for Glaucoma. Lipids 51:857-66
Kaja, Simon; Payne, Andrew J; Singh, Tulsi et al. (2015) An optimized lactate dehydrogenase release assay for screening of drug candidates in neuroscience. J Pharmacol Toxicol Methods 73:1-6
Sarkar, Saumyendra; Jun, Sujung; Simpkins, James W (2015) Estrogen amelioration of A?-induced defects in mitochondria is mediated by mitochondrial signaling pathway involving ER?, AKAP and Drp1. Brain Res 1616:101-11
Kaja, Simon; Payne, Andrew J; Naumchuk, Yuliya et al. (2015) Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes. Exp Eye Res 138:159-66
Cheli, V T; Santiago González, D A; Spreuer, V et al. (2015) Voltage-gated Ca2+ entry promotes oligodendrocyte progenitor cell maturation and myelination in vitro. Exp Neurol 265:69-83
Kaja, Simon; Sumien, Nathalie; Shah, Vidhi V et al. (2015) Loss of Spatial Memory, Learning, and Motor Function During Normal Aging Is Accompanied by Changes in Brain Presenilin 1 and 2 Expression Levels. Mol Neurobiol 52:545-54
Kaja, S; Payne, A J; Nielsen, E Ø et al. (2015) Differential cerebellar GABAA receptor expression in mice with mutations in CaV2.1 (P/Q-type) calcium channels. Neuroscience 304:198-208
Grillo, Stephanie L; Koulen, Peter (2015) Psychophysical testing in rodent models of glaucomatous optic neuropathy. Exp Eye Res 141:154-63

Showing the most recent 10 out of 233 publications